← Back to Search

Behavioral Intervention

Online Program for Chronic Disease Risk Reduction

N/A
Waitlist Available
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention (six weeks from baseline) and 4 weeks post-intervention (10 weeks from baseline).
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if an online program can help rural adults reduce their risk of chronic diseases.

Who is the study for?
This trial is for adults over 18 living in rural southern areas (RUCC 4-9) with internet access and at least one chronic disease risk factor or diagnosis. It's not open to those under 18 or non-rural residents.
What is being tested?
The study is examining a web-based intervention designed to reduce the risk of chronic diseases among rural adults, using online tools accessible via computer or smartphone.
What are the potential side effects?
Since this trial involves a web-based educational program rather than medication, traditional side effects are not applicable. However, participants may experience screen fatigue or stress from lifestyle changes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention (six weeks from baseline) and 4 weeks post-intervention (10 weeks from baseline).
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention (six weeks from baseline) and 4 weeks post-intervention (10 weeks from baseline). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Dietary Fat Intake from Baseline to Post-intervention and 4 weeks post-intervention
Change in Exercise from Baseline to Post-intervention and 4 weeks post-intervention
Change in Health Habits and Knowledge from Baseline to Post-intervention and 4 weeks post-intervention
+2 more
Secondary study objectives
Change in Sleep from Baseline to Post-intervention and 4 weeks post-intervention
Change in Social Support from Baseline to Post-intervention and 4 weeks post-intervention
Change in Social Support to Eat Better and Move More from Baseline to Post-intervention and 4 weeks post-intervention
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The participants in the intervention group received the chronic disease risk reduction intervention.
Group II: ControlActive Control1 Intervention
The participant in the control group receive usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chronic Disease Risk Reduction
2023
N/A
~80

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
224 Previous Clinical Trials
36,561 Total Patients Enrolled

Media Library

Chronic Disease Risk Reduction (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05611580 — N/A
Chronic Disease Research Study Groups: Control, Intervention
Chronic Disease Clinical Trial 2023: Chronic Disease Risk Reduction Highlights & Side Effects. Trial Name: NCT05611580 — N/A
Chronic Disease Risk Reduction (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05611580 — N/A
~27 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top